Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.53 USD | +0.47% |
|
-4.23% | -28.16% |
06-28 | Needham Trims Price Target on Rocket Pharmaceuticals to $52 From $53, Maintains Buy Rating | MT |
06-28 | Rocket Pharmaceuticals Says FDA Seeks More Information on Kresladi | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- RCKT Stock
- Revisions Rocket Pharmaceuticals, Inc.